You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 123 No. 12, December 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  New Instruments
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on ISI (19)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Ocular Imaging
 •Alert me on articles by topic

Spectral Domain Optical Coherence Tomography

Ultra-high Speed, Ultra-high Resolution Ophthalmic Imaging

Teresa C. Chen, MD; Barry Cense, PhD; Mark C. Pierce, PhD; Nader Nassif, BS; B. Hyle Park, PhD; Seok H. Yun, PhD; Brian R. White, BS; Brett E. Bouma, PhD; Guillermo J. Tearney, MD, PhD; Johannes F. de Boer, PhD

Arch Ophthalmol. 2005;123:1715-1720.

Objective  To introduce a new ophthalmic optical coherence tomography technology that allows unprecedented simultaneous ultra-high speed and ultra-high resolution.

Methods  Using a superluminescent diode source, a clinically viable ultra-high speed, ultra-high resolution spectral domain optical coherence tomography system was developed.

Results  In vivo images of the retina, the optic nerve head, and retinal blood flow were obtained at an ultra-high speed of 34.1 microseconds (ms) per A-scan, which is 73 times faster than commercially available optical coherence tomography instruments. Single images (B-scans) consisting of 1000 A-scans were acquired in 34.1 ms, allowing video rate imaging at 29 frames per second with an axial resolution of 6 µm. Using a different source in a slightly slower configuration, single images consisting of 500 A-scans were acquired in 34 ms, allowing imaging at 29 frames per second at an axial resolution of 3.5 µm, which is 3 times better than commercially available optical coherence tomography instruments. The amount of energy directed into the eye in both cases, 600 µW, is less than that of the Stratus OCT3 and is safe for intrabeam viewing for up to 8 hours at the same retinal location.

Conclusion  Spectral domain optical coherence tomography technology enables ophthalmic imaging with unprecedented simultaneous ultra-high speed and ultra-high resolution.


Author Affiliations: Department of Ophthalmology, Harvard Medical School, Boston, Mass (Dr Chen); Harvard Medical School and Wellman Center for Photomedicine, Massachusetts General Hospital, Boston (Drs Cense, Pierce, Park, Yun, Bouma, Tearney, de Boer, and Messers Nassif and White).







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.